KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Medtronic (MDT) Debt to Equity (2016 - 2026)

Medtronic (MDT) has disclosed Debt to Equity for 13 consecutive years, with $0.57 as the latest value for Q1 2026.

  • Quarterly Debt to Equity rose 6.4% to $0.57 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $0.57 through Jan 2026, up 6.4% year-over-year, with the annual reading at $0.59 for FY2025, 19.06% up from the prior year.
  • Debt to Equity hit $0.57 in Q1 2026 for Medtronic, down from $0.6 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $0.6 in Q4 2025 to a low of $0.44 in Q3 2022.
  • Historically, Debt to Equity has averaged $0.52 across 5 years, with a median of $0.51 in 2022.
  • Biggest five-year swings in Debt to Equity: fell 19.85% in 2022 and later increased 19.74% in 2024.
  • Year by year, Debt to Equity stood at $0.51 in 2022, then decreased by 5.03% to $0.49 in 2023, then grew by 19.74% to $0.58 in 2024, then rose by 2.44% to $0.6 in 2025, then decreased by 4.2% to $0.57 in 2026.
  • Business Quant data shows Debt to Equity for MDT at $0.57 in Q1 2026, $0.6 in Q4 2025, and $0.59 in Q3 2025.